ArticleFrontiers in bioengineering and biotechnology2019
The National Security Implications of Cyberbiosecurity.
Article in Frontiers in bioengineering and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Improving governance in the age of synthetic biology, artificial intelligence, and diverging threats.Frontiers in bioengineering and biotechnology · 2026Article
- Editorial: Systems and network approaches to precision medicine and healthcare.Frontiers in molecular biosciences · 2024Article
- Facing the 2020 pandemic: What does cyberbiosecurity want us to know to safeguard the future?Biosafety and health · 2021Review
- Advances in Synthetic Biology and Biosafety Governance.Frontiers in bioengineering and biotechnology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cyber- and biological sciences are converging rapidly, creating benefits, new and advantageous applications, and increasing risks to all nations. The parts of the public and private sectors that should be responsible for cyberbiosecurity are not yet sufficiently organized or supported financially. This article addresses the need to ensure that national security policy: (1) assesses cyberbiological risk and incorporates deterrent and enforcement measures; (2) sets forth clear consequences for those individuals and countries that conduct cyberbiological attacks or otherwise compromise cyberbiosecurity, without imperiling the legitimate sharing of scientific data and information; (3) establishes voluntary cyberbiosecurity standards in partnership with the private sector; (4) identifies cyberbiosecurity threats, vulnerabilities, consequences, and solutions; and (5) results from the combined efforts of all branches of government and the private sector.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.